ERICA UNDERWOOD: Open Payments
NPI 1932653839 · ST PETERSBURG, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$404 in 18 payments from 11 companies in 2025. Trend: 2023 $426 · 2024 $1,062 · 2025 $404
Food & beverage: $404
| Company | Payments | Amount |
|---|---|---|
| GENZYME CORPORATION | 2 | $80 |
| ABBVIE INC. | 3 | $67 |
| Janssen Biotech, Inc. | 3 | $50 |
| Novartis Pharmaceuticals Corporation | 2 | $45 |
| Lilly USA, LLC | 1 | $35 |
| Hill Dermaceuticals, Inc. | 1 | $34 |
| Amgen Inc. | 1 | $24 |
| Fidia Pharma USA Inc. | 1 | $20 |
| STRATA Skin Sciences, Inc. | 1 | $18 |
| PFIZER INC. | 1 | $17 |
Products named: DUPIXENT, SKYRIZI, TREMFYA, EBGLYSS, Tolak, OTEZLA, XTRAC, COSENTYX.
Industry payments across FL — which companies pay providers there.
